HealthEquity (HQY) Stock Price, News & Analysis

Company Overview

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Key Stats

• Today's Range: $101.21 to $103.70
• 50-Day Range: $76.58 to $102.96
• 52-Week Range: $62.10 to $103.69
• Volume: 772,678 shs
• Average Volume: 745,149 shs
• Market Capitalization: $8.99 billion
• P/E Ratio: 85.80
• Dividend Yield: N/A
• Price Target: $107.23
• Consensus Rating: Moderate Buy

HealthEquity Stock Analysis - MarketRank™

HealthEquity scored higher than 73% of companies evaluated by MarketBeat, and ranked 291st out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

HealthEquity has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

HealthEquity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 25.11%

Earnings Growth

Earnings for HealthEquity are expected to grow by 25.11% in the coming year, from $2.27 to $2.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of HealthEquity is 85.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of HealthEquity is 85.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 97.34.

Price to Earnings Growth Ratio

HealthEquity has a PEG Ratio of 1.61. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

HealthEquity has a P/B Ratio of 4.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.80% of the outstanding shares of HealthEquity have been sold short.

Short Interest Ratio / Days to Cover

HealthEquity has a short interest ratio ("days to cover") of 7.3.

Change versus previous month

Short interest in HealthEquity has recently decreased by 4.99%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

HealthEquity does not currently pay a dividend.

Dividend Growth

HealthEquity does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.80% of the outstanding shares of HealthEquity have been sold short.

Short Interest Ratio / Days to Cover

HealthEquity has a short interest ratio ("days to cover") of 7.3.

Change versus previous month

Short interest in HealthEquity has recently decreased by 4.99%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.89

News Sentiment

HealthEquity has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for HealthEquity this week, compared to 7 articles on an average week.

Search Interest

Only 1 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

6 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $884,517.00 in company stock.

Percentage Held by Insiders

Only 2.20% of the stock of HealthEquity is held by insiders.

Percentage Held by Institutions

99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HQY Stock Analysis - Frequently Asked Questions

How have HQY shares performed this year?

HealthEquity's stock was trading at $66.30 at the start of the year. Since then, HQY shares have increased by 55.3% and is now trading at $102.96.
View the best growth stocks for 2024 here.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Tuesday, September, 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a trailing twelve-month return on equity of 9.01%.

Who are HealthEquity's major shareholders?

Top institutional shareholders of HealthEquity include Wasatch Advisors LP (8.89%), FMR LLC (6.06%), State Street Corp (3.59%) and Geode Capital Management LLC (2.38%). Insiders that own company stock include Jon Kessler, Ian Sacks, Stephen Neeleman, Tyson D Murdock, Elimelech Rosner, Edward Bloomberg, Robert W Selander, Delano Ladd, Larry L Trittschuh, Evelyn S Dilsaver, Gayle Furgurson Wellborn, Debra Charlotte Mccowan, Frank Corvino, Angelique Christine Hill, Stuart B Parker and Adrian T Dillon.
View institutional ownership trends.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that HealthEquity investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Netflix (NFLX), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

• Last Earnings: 9/03/2024
• Today: 11/21/2024
• Next Earnings (Confirmed): 12/09/2024
• Fiscal Year End: 1/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Business services, not elsewhere classified
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:HQY
• CUSIP: N/A
• CIK: 1428336
• Web: www.healthequity.com
• Phone: (801) 727-1000
• Fax: 801-727-1005
• Employees: 3,150
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $107.23
• High Stock Price Target: $130.00
• Low Stock Price Target: $92.00
• Potential Upside/Downside: +4.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.92
• Research Coverage: 13 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.20
• Trailing P/E Ratio: 85.80
• Forward P/E Ratio: 45.36
• P/E Growth: 1.55
• Net Income: $55.71 million
• Net Margins: 9.61%
• Pretax Margin: 11.89%
• Return on Equity: 9.01%
• Return on Assets: 5.73%

Debt

• Debt-to-Equity Ratio: 0.51
• Current Ratio: 4.10
• Quick Ratio: 4.10

Sales & Book Value

• Annual Sales: $999.59 million
• Price / Sales: 8.99
• Cash Flow: $3.56 per share
• Price / Cash Flow: 28.95
• Book Value: $23.72 per share
• Price / Book: 4.34

Miscellaneous

• Outstanding Shares: 87,320,000
• Free Float: 85,403,000
• Market Cap: $8.99 billion
• Optionable: Optionable
• Beta: 0.52